Replies to post #53048 on US Stem Cell Inc (USRM)

[4toSchool]

We're past the 60-days because USRM submitted their RMAT application on January 27th, 2017.

On January 27, 2017, U.S. Stem Cell, Inc. applied for the FDA’s new Regenerative Medicine Advanced Therapy (RMAT) designation for the MyoCell™ product as part of the MARVEL trial.

http://us-stemcell.com/en/ceo-blog-exciting-accomplishments-in-april/